Day

oktober 23, 2018
23RD OCTOBER 2018 EB8018, the lead investigational candidate, targets Crohn’s disease with potential for other GI disorders Paris, France and Cambridge, MA, USA – October 23, 2018 ENTEROME SA, a clinical-stage biotech company developing innovative therapies to treat microbiome-associated diseases with a focus on auto-immune disease and cancer, has entered into a global licensing, co-development and co-promotion...
Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announces that data from a phase I study assessing the safety and tolerability of its lead drug candidate SNF472 in haemodialysis patients has been published in the British Journal of Clinical...
Et hold forskere på Københavns Universitet har ved at arbejde med myrehjerner identificeret helt basale DNA-netværk, der med stor sandsynlighed kan siges at styre hjerneaktivitet. Opdagelsen er netop offentliggjort i det videnskabelige tidsskrift Nature Ecology and Evolution. Metoden kan bruges til at udforske sammenhænge mellem generelle hjernefunktioner og social adfærd. Hvilke gener skal tændes og...

Nyheder

Ny analysemetode afslører kroppens politimænd
19. november 2018
Verdens eneste terningformede lort kan nu forklares videnskabeligt
19. november 2018
Genetisk hurtigløb – hele vejen ned gennem det amerikanske kontinent
9. november 2018

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge